Arterius
Leeds
About Arterius
Arterius Limited is developing a novel next-generation polymer-based Bio-resorbable Coronary Scaffold (BRS), more commonly known as a ‘stent’. The bio-resorbable attribute allows the stent to dissolve over time, typically 12–24 months, before being absorbed by the body. Therefore, there is no requirement to physically remove the stent. The Company’s solution offers a huge opportunity to minimise the frequency of surgery or medical interventions and could give patients a better post-operative quality of life.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $349.0K
- Funding stage: Seed
- Last round: Grant (Jan 2016)
- Website: arterius.co.uk
- Phone: 0113 4264300
Industries & Categories
Biotechnology, Health Care, Life Science, Medical, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/arterius-2445708 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.